Icade SA
F:3IC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Icade SA
F:3IC
|
FR |
|
M
|
Merck KGaA
XMUN:MRK
|
DE |
Intrinsic Value
The intrinsic value of 
Icade SA (3IC) under the Base Case is 35.24 EUR per share.
Compared with the current market price of 14.73 EUR, the stock appears
Undervalued by 58% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Icade Does
Icade SA is a French real estate company that owns, develops, and manages property. Its business is split between commercial real estate, such as offices and business parks, and property development, where it builds and sells homes and other buildings. It also has a major presence in healthcare real estate, owning specialized buildings like clinics and medical facilities.
- Headquarters
- France FR
- Employees
- 984
- IPO date
- Jan 7, 1985
Earnings Waterfall
Icade SA
The intrinsic value for Icade SA (3IC) under the Base Case is 35.24 EUR.
Compared with the current market price of 14.73 EUR, the stock appears Undervalued by 58% .